NHS launches groundbreaking sickle cell gene therapy
By Lee Peart 31 January 2025
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
Director of Families, Quality & Commissioning
£126,543 to £132,441
Lewisham, London (Greater)£126,543 to £132,441
Executive Director of Adult Social Care & Health (DASS)
£166,755 to £173,133
Lewisham, London (Greater)£166,755 to £173,133
Assessor Coach
£31,537- £34,434 pro rata per annum
Northallerton, North Yorkshire£31,537- £34,434 pro rata per annum
Most Read News
Director of Families, Quality & Commissioning
£126,543 to £132,441
Lewisham, London (Greater)£126,543 to £132,441
Executive Director of Adult Social Care & Health (DASS)
£166,755 to £173,133
Lewisham, London (Greater)£166,755 to £173,133
Assessor Coach
£31,537- £34,434 pro rata per annum
Northallerton, North Yorkshire£31,537- £34,434 pro rata per annum
Most Read News
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
